Boron microlocalization in oral mucosal tissue: implications for boron neutron capture therapy
2000

Boron Microlocalization in Oral Mucosal Tissue for Cancer Therapy

publication Evidence: moderate

Author Information

Author(s): Morris G M, Smith D R, Patel H, Chandra S, Morrison G H, Hopewell J W, Rezvani M, Micca P L, Coderre J A

Primary Institution: Research Institute, University of Oxford

Hypothesis

How does the microdistribution of boron-10 in oral mucosa affect the biological effectiveness of boron neutron capture therapy?

Conclusion

The study found that the microdistribution of boron-10 significantly affects the response of oral mucosa to boron neutron capture irradiation.

Supporting Evidence

  • The study evaluated two boron delivery agents, borocaptate sodium (BSH) and p-boronophenylalanine (BPA), in a rat model.
  • 10B concentrations were significantly lower in the epithelium after BSH administration compared to BPA.
  • The CBE factor for BSH was estimated at 0.29 ± 0.02, indicating lower effectiveness than BPA's CBE factor of 4.87 ± 0.16.

Takeaway

This study looks at how boron is distributed in the mouth and how that affects cancer treatment with special radiation therapy.

Methodology

The study used ion microscopy to analyze boron-10 concentrations in rat ventral tongue mucosa after administering two boron delivery agents.

Limitations

The study was conducted on rats, which may not fully represent human responses.

Statistical Information

Confidence Interval

0.29 ± 0.02 for BSH; 4.87 ± 0.16 for BPA

Digital Object Identifier (DOI)

10.1054/bjoc.2000.1148

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication